Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 4 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Results 1 - 20 of 39 : 1 2 Next »

Recs

0
Member Avatar griderX (96.40) Submitted: 9/14/2015 11:54:17 AM : Outperform Start Price: $15.19 CLDX Score: -79.01

Speculative Buy List

Recs

0
Member Avatar TMFInnovator (32.28) Submitted: 8/17/2015 10:14:19 PM : Outperform Start Price: $16.71 CLDX Score: -76.10

No commercial products yet, but I think they have a pretty solid pipeline:

http://www.celldex.com/pipeline/pipeline-overview.php

Recs

0
Member Avatar Med51 (61.66) Submitted: 5/21/2015 11:41:16 PM : Outperform Start Price: $27.19 CLDX Score: -82.14

If even one of their drugs makes it to market they will make a very healthy profit and revenue stream.

Recs

0
Member Avatar ptanabe (< 20) Submitted: 2/26/2015 6:29:50 PM : Outperform Start Price: $21.93 CLDX Score: -82.66

BTD

Recs

0
Member Avatar sullyz0r (32.80) Submitted: 11/25/2014 10:22:45 PM : Outperform Start Price: $20.38 CLDX Score: -79.91

A bit late on this one, but better late than later.

Recs

1
Member Avatar asilverp (66.56) Submitted: 8/28/2014 12:25:20 PM : Underperform Start Price: $15.94 CLDX Score: +77.98

p/s of over 500 and losing money.

Recs

0
Member Avatar stockgripes (99.27) Submitted: 8/21/2014 4:05:09 PM : Outperform Start Price: $14.30 CLDX Score: -75.53

time to switch the thumb again

Recs

0
Member Avatar wimmreuter (42.71) Submitted: 9/26/2013 2:22:01 PM : Outperform Start Price: $35.18 CLDX Score: -110.50

Coming down from the high 80s and now slowly being successful with their medication is the a long way to go but rewards are coming.

Recs

0
Member Avatar Teknowizz (68.56) Submitted: 9/25/2013 3:06:12 AM : Outperform Start Price: $34.48 CLDX Score: -110.03

OK let's see whether she will run some more.
Really stopped this too early in order to bank the +300 run :)

Recs

2
Member Avatar bignr15 (< 20) Submitted: 7/7/2013 3:36:34 PM : Outperform Start Price: $21.40 CLDX Score: -107.23

Huge Growth Potential, could hit $60 in 2 years. Will be lots of ups and downs, so have long term view on this one.

Recs

0
Member Avatar FoolsLint (< 20) Submitted: 7/6/2013 4:59:20 PM : Outperform Start Price: $21.40 CLDX Score: -107.23

The demand for cancer cure. The success this company is having . The effect that this company is having on breast cancer is a very good start.

Recs

0
Member Avatar TheStockDoctor (< 20) Submitted: 6/11/2013 7:15:03 AM : Outperform Start Price: $15.14 CLDX Score: -99.93

Pipeline is strong and competition is minimal.

Recs

1
Member Avatar MyManDon1 (< 20) Submitted: 7/20/2012 11:38:21 AM : Outperform Start Price: $5.38 CLDX Score: -76.48

1) market cap of only $300MM
2) has cash on hand to get through PIII with leading drugs
3) owns most important drugs outright keeping significant potential for homegrown profits inhouse and/or leaving room for partnership and/or full buyout
4) multiple drugs in pII providing cushion agains setback (i.e. limited downside risk)
5) management/science presentations exhibit sound planning and strategy that is needed to succeed
6) partnership activity is picking up due to patent cliffs at many big pharmas

Recs

1
Member Avatar rangarajud (< 20) Submitted: 5/16/2012 5:31:51 PM : Outperform Start Price: $4.47 CLDX Score: -65.81

great stock with huge pipeline and promising drug status on May 23rd 2012 will send this stock north of 7$.

Recs

1
Member Avatar stainsolution (35.81) Submitted: 4/24/2012 3:24:49 PM : Outperform Start Price: $3.96 CLDX Score: -49.56

ASCO run---might be a little early here.

Recs

1
Member Avatar RBuskey106 (49.51) Submitted: 3/21/2012 8:22:30 PM : Outperform Start Price: $4.77 CLDX Score: -63.47

ASCO pick

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 5/16/2011 12:43:10 PM : Outperform Start Price: $3.52 CLDX Score: -42.70

irishred1

Recs

0
Member Avatar Khatte (< 20) Submitted: 4/11/2011 8:54:38 PM : Outperform Start Price: $4.10 CLDX Score: -59.08

It appears that CLDX is entering phase III of clinical trials on it's new immune based cancer treatments with strong results in earlier phases.

Recs

0
Member Avatar sjc40 (< 20) Submitted: 2/18/2011 6:57:39 PM : Outperform Start Price: $3.60 CLDX Score: -45.87

as a physician i think this is the best of all biotech

Recs

0
Member Avatar julianna8 (< 20) Submitted: 10/7/2010 4:34:28 PM : Outperform Start Price: $4.32 CLDX Score: -85.20

taking a gamble on this one.

Results 1 - 20 of 39 : 1 2 Next »

Featured Broker Partners